Cerebral Palsy

• CLINICAL_TRIALS withdrawal · 2025-09-29
  Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy

  Expanded access IND for Hope Biosciences' autologous adipose-derived mesenchymal stem cells to treat cerebral palsy is no longer available.

• CLINICAL_TRIALS withdrawal · 2025-08-05
  Clinical Trial Update: Promoting Upright Mobility in Infants With Cerebral Palsy Using a Robotic Unweighting System [Phase 2]

  A Phase 2 clinical trial evaluating a robotic unweighting system to promote upright mobility in infants with cerebral palsy has been withdra…

• CLINICAL_TRIALS withdrawal · 2025-07-10
  Clinical Trial Update: Cerebral pAlsy Motor Promotion With Transcranial Direct Current Stimulation (CAMP-tDCS) [NA]

  The CAMP-tDCS trial investigating motor promotion in cerebral palsy with hemiplegia has been withdrawn from clinicalTrials.gov.

• CLINICAL_TRIALS withdrawal · 2024-11-19
  Clinical Trial Update: Dopamine and Motor Learning in Cerebral Palsy

  The NIH Clinical Center terminated the clinical trial investigating dopamine and motor learning in cerebral palsy.

• CLINICAL_TRIALS withdrawal · 2024-10-08
  Clinical Trial Update: Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy [NA]

  A clinical trial evaluating a bilateral activities of daily living exercise robot for stroke therapy was withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2024-07-25
  Clinical Trial Update: Pediatric Neural Sleeve Validation [NA]

  A pediatric trial (NCT05660096) studying neural sleeve validation for cerebral palsy has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-08-29
  Clinical Trial Update: Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy [Phase 4]

  A Phase 4 placebo-controlled trial of baclofen for gastroesophageal reflux disease in children with cerebral palsy has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-11-19
  Clinical Trial Update: FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy [Phase 2]

  Phase 2 trial evaluating FLT-PET activity after allogeneic umbilical cord blood therapy in cerebral palsy has been withdrawn.